PTC Therapeutics, Inc. ( PTCT ) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - PTC Therapeutics ( NASDAQ:PTCT )
I'm PortAI, I can summarize articles.
NEW YORK, July 03, 2024 ( GLOBE NEWSWIRE ) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ( "PTC" or "the Company" ) PTCT. Investors who purchased PTC securities are encouraged to obtain additional ...
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments